Kat McGowan | January 31, 2013 We’re moving from a world of genetic scarcity to one of genetic abundance, said InVitae CEO Randy Scott at the 2013 Personalized Medicine World Conference in Mountain View, Calif., on Wednesday. It’s a transition…

Turna Ray | January 30, 2013 InVitae, a company specializing in using targeted next-generation sequencing to diagnose rare genetic diseases, is preparing to launch this year a $1,500 test to assess 270 inherited conditions. Randy Scott, former Genomic Health executive…

Ron Leuty | January 18, 2013 In Randy Scott‘s world, parents are tested for hundreds of diseases they could quietly carry within their genes, children’s diseases are discovered early enough for treatment, doctors order those tests easily and the results feed…

Luke Timmerman | January 18, 2013 You could call Randy Scott an E.F. Hutton for the genomics business. People listen when the co-founder and former CEO of Genomic Health talks. And Scott isn’t just talking. He’s gone “all-in,” putting his…

Kevin Davies | November 30, 2012 Receiving the 2012 Leadership in Personalized Medicine Award from the Personalized Medicine Coalition (PMC), Randy Scott reflected on his success as the founder and former CEO of Genomic Health, but also looked ahead to new…

Genomic Health Announces Second Quarter 2012 Financial Results and Business Progress – Product Revenue Increased 13% Compared with Prior Year – - Delivered Net Income of $1.8 Million – - Began Offering Oncotype DX® Colon Cancer Test for Stage III…

Genomic Health Announces Formation of New Genetics Subsidiary New Venture to Focus on Integrating Clinically Relevant Genetic Information from the Human Genome into Routine Medical Practice Randy Scott to Lead Subsidiary, Kim Popovits to Assume Role of Chairman of Genomic…